Skip to main content

Advertisement

Table 2 Demographic data comparing respondents to non-respondents (N = 3435)

From: A national physician survey on prescribing syringes as an HIV prevention measure

  Respondents (N = 588) Non-Respondents (N = 1971) Chi-square p-value
Gender    
   Female 29.8% (175) 24.9% (491) 0.01
Age (mean ± std)    
   Age: 49.3 ± 11.2 51.1 ± 12.4 0.0009
Specialty    
   Primary 81.3% (478) 85.6% (1687) 0.0001
   Emergency Medicine 12.9% (76) 8.3% (164)  
   Specialist 5.8% (34) 6.1% (120)  
Region    
   Northeast 26.2% (152) 24.7% (487) 0.75
   South 26.7% (155) 28.8% (568)  
   Midwest 23.2% (135) 23.1% (455)  
   West 23.9% (139) 23.4% (461)  
Homestate syringe law    
   Strict Prohibition 27.0% (149) 30.4% (599) 0.12
   Access Intermediate 40.1% (221) 40.6% (800)  
   Open access syringe sales 32.8% (181) 29.0% (572)  
Syringe Exchange Program    
   Legal SEP 52.8% (309) 50.0% (986) 0.12
   SEP w/o claim to legal 27.2% (159) 26.1% (514)  
   No SEP operating 20.0% (117) 23.9% (471)